A Study of BG-C477 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
310 enrolled
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
90 enrolled
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Phase 2/3 Recruiting
840 enrolled
TroFuse-031
Phase 3 Recruiting
590 enrolled
Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002
Phase 1 Recruiting
66 enrolled
A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01
Phase 1 Recruiting
70 enrolled
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Phase 3 Recruiting
800 enrolled
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Phase 2/3 Recruiting
550 enrolled
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Phase 2 Recruiting
40 enrolled
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Phase 2 Recruiting
99 enrolled
QuANTUM-WILD
Phase 3 Recruiting
700 enrolled
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
Phase 1 Recruiting
217 enrolled
Morpheus-panBC
Phase 1/2 Recruiting
792 enrolled
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Phase 3 Recruiting
726 enrolled
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
330 enrolled
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
Phase 2 Recruiting
40 enrolled
A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias
Phase 1 Recruiting
76 enrolled
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 Recruiting
710 enrolled
A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer
Phase 1 Recruiting
328 enrolled
DESTINY-Lung06
Phase 3 Recruiting
686 enrolled
A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer(NSCLC) Patients
Phase 2 Recruiting
240 enrolled
KYANITE-1
Phase 1/2 Recruiting
250 enrolled
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Phase 2/3 Recruiting
135 enrolled
AREAL
Phase 2 Recruiting
124 enrolled
SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors
Phase 2 Recruiting
340 enrolled
AK129 Combination Therapy for Advanced Solid Tumors
Phase 1/2 Recruiting
230 enrolled
MATISSE
Phase 2 Recruiting
70 enrolled
A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)
Phase 2 Recruiting
50 enrolled
Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer
Phase 2 Recruiting
150 enrolled
A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer
Phase 3 Recruiting
432 enrolled
An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer
Phase 2 Recruiting
172 enrolled
A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer
Phase 3 Recruiting
420 enrolled
A Study of IBI363 in Subjects With Advanced Malignancies
Phase 1 Recruiting
556 enrolled
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies
Phase NA Recruiting
30 enrolled
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Recruiting
5,000 enrolled
A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer
Phase 2 Recruiting
58 enrolled